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Spirulina or Arthrospira is a blue-green alga that became famous after it was successfully used by NASA as a dietary supplement
for astronauts on space missions. It has the ability to modulate immune functions and exhibits anti-inﬂammatory properties by
inhibiting the release of histamine by mast cells. Multiple studies investigating the eﬃcacy and the potential clinical applications of
Spirulina in treating several diseases have been performed and a few randomized controlled trials and systematic reviews suggest
that this alga may improve several symptoms and may even have an anticancer, antiviral and antiallergic eﬀects. Current and
potential clinical applications, issues of safety, indications, side-eﬀects and levels of evidence are addressed in this review. Areas of
ongoing and future research are also discussed.
1.Introduction
Spirulina is a microscopic and ﬁlamentous cyanobacterium
that derives its name from the spiral or helical nature of
its ﬁlaments. It has a long history of use as food and it
has been reported that it has been used during the Aztec
civilization [1]. Spirulina refers to the dried biomass of
Arthrospira platensis, an oxygenic photosynthetic bacterium
found worldwide in fresh and marine waters. This alga
represents an important staple diet in humans and has
been used as a source of protein and vitamin supplement
in humans without any signiﬁcant side-eﬀects. Apart from
the high (up to 70%) content of protein, it also contains
vitamins, especially B12 a n dp r o vi t a m i nA( β-carotenes), and
minerals, especially iron. It is also rich in phenolic acids,
tocopherols and γ-linolenic acid [1]. Spirulina lacks cellulose
cell walls and therefore it can be easily digested [1].
Many toxicological studies have proven Spirulina’s safety.
Spirulina now belongs to the substances that are listed by
the US Food and Drug Administration under the category
Generally Recognized as Safe (GRAS) [2–6]. Spirulina is
relatively easy to cultivate but ﬂourishes only in alkaline
lakes with an extremely high pH and in large outdoor ponds
under controlled conditions. There are only a few areas
worldwide that have the ideal sunny climate for production
of this alga, including Greece (Nigrita, Serres), Japan, India,
United States and Spain. Currently, Spirulina can be found in
health food stores and is sold mainly as a dietary supplement
in the form of health drinks or tablets. Microalgae have
been used for more than 10 years as dietary supplements
without signiﬁcant side-eﬀects [7] .T h ea i m so ft h i sr e v i e w
are to summarize the mechanisms of action, highlight the
potential eﬀects of this alga in humans and address current
and possible future clinical applications, based mainly on in
vivo studies and a few well-designed in vitro studies and the
highest levels of evidence available in the literature.
2. Evidence-BasedApplications ofSpirulina
2.1. Spirulina and Chronic Fatigue. Spirulina has been
promoted as “the food of the future” with “exceptional
constituents” that contribute to high energy levels. A few of
these constituents such as polysaccharides (Rhamnose and
Glycogen) and essential fat (GLA) are absorbed easily by
human cells and help in energy release. Spirulina increases
healthylactobacillusintheintestine,enablingtheproduction
of Vitamin B6 that also helps in energy release. Despite
this promotion, the only available placebo-controlled ran-
domized trial showed that the scores of fatigue were not2 Evidence-Based Complementary and Alternative Medicine
signiﬁcantly diﬀerent between spirulina and placebo. Spir-
ulina administered at a dose of 3g day−1 did not ameliorate
fatigue more than the placebo in any of the four subjects and
possibly it has no eﬀect on chronic fatigue [8].
2.2. Allergy, Rhinitis, and Immunomodulation. It has been
well documented that Spirulina exhibits anti-inﬂammatory
properties by inhibiting the release of histamine from mast
cells [9, 10].
Inarecentrandomized,double-blindplacebo-controlled
trial [11], individuals with allergic rhinitis were fed daily,
either with placebo or Spirulina for 12 weeks. Peripheral
blood mononuclear cells were isolated before and after
the Spirulina feeding and levels of cytokines (interleukin-
4 (IL-4), interferon-γ (IFN-γ) and interleukin-2), which
areimportantinregulatingimmunoglobulin(Ig)E-mediated
allergy, were measured. The study showed that high dose of
Spirulina signiﬁcantly reduced IL-4 levels by 32%, demon-
stratingtheprotectiveeﬀectsofthismicroalgatowardallergic
rhinitis.




A Japanese team identiﬁed the molecular mechanism of
the human immune capacity of Spirulina by analysing blood
cells of volunteers with pre- and post-oral administration of
hot water extract of Spirulina platensis.I F N - γ production
and Natural Killer (NK) cell damage were increased after
administration of the microalga extracts to male volunteers
[13].
In a recent double-blind, placebo-controlled study from
Turkey evaluating the eﬀectiveness and tolerability of Spir-
ulina for treating patients with allergic rhinitis, Spirulina
consumption signiﬁcantly improved the symptoms and
physical ﬁndings compared with placebo (P<. 001),
including nasal discharge, sneezing, nasal congestion and
itching [14].
It is well understood that deﬁciency of nutrients is
responsible for changes in immunity, which manifests as
changes in production of T-cells, secretory IgA antibody
response, cytokines and NK-cell activity. The above studies
suggest that Spirulina may modulate the immune system by
its role in covering nutritional deﬁciencies.
2.3. Antiviral Applications: In Vitro Studies. There are no in
vivo studies providing strong evidence supporting the possi-
ble antiviral properties of Spirulina. The active component
of the water extract of S. platensis is a sulfated polysac-
charide, calcium spirulan (Ca-Sp). According to Hayashi et
al. [15], Ca-Sp inhibits the in vitro replication of several
enveloped viruses including Herpes simplex type I, human
cytomegalovirus, measles and mumps virus, inﬂuenza A
virus and human immunodeﬁciency virus-1 virus (HIV-1).
Another more recent study showed in vitro that an
aqueous extract of S. platensis inhibited HIV-1 replication
in human T-cells, peripheral blood mononuclear cells and
Langerhan cells [16]. The advantage of using herbs and
algal products with proven antiviral properties in ﬁght-
ing certain viruses is that they can be used—through
immunomodulation—even when the infection is estab-
lished.
Of course, the above promising eﬀects need to be studied
further in animal models and humans before any deﬁnitive
conclusions are drawn.
2.4. Cholesterol-Lowering Eﬀects and Eﬀects on Diabetes.
Cardiovascular disease remains the number one cause of
death in developed countries, despite increased awareness,
and high cholesterol is one of the most important risk factors
in atherosclerosis.
Nakaya et al. [17], in the ﬁrst human study, gave 4.2g
day−1 of Spirulina to 15 male volunteers and, although
there was no signiﬁcant increase in high-density lipoprotein
(HDL) levels, they observed a signiﬁcant reduction of
high-density lipoprotein (LDL) cholesterol after 8 weeks of
treatment. The atherogenic eﬀect also declined signiﬁcantly
in the above group [17].
Ramamoorthy and Premakumari [18] in a more recent
study administered Spirulina supplements in ischemic heart
disease patients and found a signiﬁcant reduction in blood
cholesterol,triglyceridesandLDLcholesterolandanincrease
in HDL cholesterol. More research is needed before Spirulina
can be recommended to lower cholesterol levels but its role
as a natural food supplement in combating hyperlipidaemia,
in combination with other therapeutic options, should not
be overlooked.
Finally, Mani et al. [19] in a clinical study, found a
signiﬁcant reduction in LDL:HDL ratio in 15 diabetic
patients who were given Spirulina. However, this study was
small and better studies are needed before Spirulina can be
recommended in diabetes.
2.5. Anticancer Eﬀects. It has been argued that the combined
antioxidant and immune modulation characteristics of Spir-
ulina may have a possible mechanism of tumor destruction
and hence play a role in cancer prevention. Whilst there are
many animal and in vitro studies, there has been only one
trial with human subjects. This study looked speciﬁcally at
the eﬀects of Spirulina on oral carcinogenesis, in particular
leukoplakia [20]. It is not surprising that few human studies
exist to date as cancer prevention trials with lower cancer
incidence as an endpoint have logistic problems, rendering
them essentially impossible to conduct for most malignan-
cies. The study conducted by Mathew et al. on a cohort
of 77 patients originates from previous trials on hamsters
that showed tumor regression after topical application or
enteral intake of Spirulina extract [21–23]. They reported
that 45% of their study cohort showed complete regression
of leukoplakia after taking Spirulina supplements for 1 year.
The authors also reported that there was no rise in the serum
concentration of retinal β-carotene despite supplementation
and concluded that other constituents within Spirulina may
have been responsible for the anticancer eﬀects. Whilst
their results appear promising, it was an unblinded, non-
randomized trial and as such cannot be regarded as evidence
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2.6. Chronic Arsenic Poisoning: A Randomized Trial. Millions
of people in Bangladesh, India, Taiwan and Chile are
consuming high concentration of arsenic through drinking
water and are at risk of chronic arsenic poisoning for which
there is no speciﬁc treatment. A placebo-controlled, double-
blind study was conducted to evaluate the eﬀectiveness of
spirulina extract plus zinc in the treatment of chronic arsenic
poisoning [24]. Forty-one patients with chronic arsenic
poisoning were randomly treated by either placebo (17
patients) or spirulina extract (250mg) plus zinc (2mg) (24
patients) twice daily for 16 weeks. Each patient was supplied
with arsenic-safe drinking water by installing a locally made
water ﬁlter at household level. Eﬀectiveness of spirulina
extract plus zinc was evaluated by comparing changes in skin
manifestations (clinical scores) and arsenic contents in urine
and hair, between the placebo- and spirulina extract plus
zinc-treated groups. Results showed that spirulina extract
plus zinc twice daily for 16 weeks may be useful for the
treatment of chronic arsenic poisoning with melanosis and
keratosis.Morerandomizedtrialsarerequiredbuttheresults
are promising.
2.7. Antioxidant Eﬀe c t s :N oI nV i v oS t u d i e s .C-phycocyanin
(C-PC) is one of the major biliproteins of Spirulina with
antioxidant and radical scavenging properties. C-PC, a
selective cyclooxygenase-2 inhibitor, induces apoptosis in
lipopolysaccharide-stimulated RAW 264.7 macrophages. It
is also known to exhibit anti-inﬂammatory and anticancer
properties [25]. To date though, there are no in vivo human
studies on possible antioxidant eﬀects of Spirulina.
3. Conclusions
The positive eﬀects of Spirulina in allergic rhinitis are based
on adequate evidence but larger trials are required. It is
believed that the anticancer eﬀects of Spirulina are perhaps
derived from β-carotene, a known antioxidant; however,
the link between β-carotene level and carcinogenesis cannot
be established as the etiology of carcinoma is frequently
multifactorial [26, 27]. There are some positive studies
on the cholesterol-lowering eﬀects of Spirulina but larger
studies are required before any deﬁnitive conclusions can be
made. Finally, there are no high-level evidence trials on the
role played by Spirulina in chronic fatigue and in antiviral
applications. At the moment, what the literature suggests is
that Spirulina is a safe food supplement without signiﬁcant
side-eﬀects but its role as a drug remains to be seen.
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